Research Progress on the Expression of miRNA in the Diagnosis and Treatment of Bladder Urothelial Carcinoma

Wei Lin; Zhang Yujun

doi:10.23977/tranc.2024.050101

Research Progress on the Expression of miRNA in the Diagnosis and Treatment of Bladder Urothelial Carcinoma

Download as PDF

DOI: 10.23977/tranc.2024.050101 | Downloads: 9 | Views: 198

Author(s)

Wei Lin ¹, Zhang Yujun ²

Affiliation(s)

¹ Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
² Affiliated Hospital of Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712000, China

Corresponding Author

Zhang Yujun

ABSTRACT

As one of the most common highly invasive tumors in the urinary system, bladder cancer has a high incidence rate and recurrence rate due to the lack of accurate biomarkers. MicroRNA (miRNA) is a non coding microRNA that regulates human gene expression and participates in cell growth cycle, development, proliferation, apoptosis, and differentiation. Studies have found that miRNA can affect the proliferation, invasion, metastasis and other malignant biological behaviors of bladder cancer through various ways, and may become a new biomarker in the early diagnosis, treatment and prognosis of bladder cancer. This article reviews the research progress of miRNA expression in the diagnosis and treatment of bladder cancer.

KEYWORDS

miRNA; Bladder cancer; Targeted therapy

CITE THIS PAPER

Wei Lin, Zhang Yujun, Research Progress on the Expression of miRNA in the Diagnosis and Treatment of Bladder Urothelial Carcinoma. Transactions on Cancer (2024) Vol. 5: 1-7. DOI: http://dx.doi.org/10.23977/tranc.2024.050101.

REFERENCES

[1] Li Jun, Xiong Ying, Zhao Qi, et al. The biological functions and clinical significance of exosomal microRNAs in the development of bladder cancer[J]. Journal of Modern Oncology, 2023, 31(23):4449-4455.
[2] Zoraida Andreu, Renan Otta Oshiro, Alberto Redruello, et al. Extracellular vesicles as a source for non-invasive biomarkers in bladder cancer progression[J]. European Journal of Pharmaceutical Sciences, 2016, 98:70-79.
[3] ElShal Amal S, Shalaby Sally M, Abouhashem Safwat E, et al. Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer [J]. Molecular biology reports, 2021, 48(5):1-11.
[4] Güllü Amuran Gökçe, et al. Urinary micro-RNA expressions and protein concentrations may differentiate bladder cancer patients from healthy controls [J]. International urology and nephrology, 2020, 52(3):461-468.
[5] Armstrong David A, Green Benjamin B, Seigne John D, et al. MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer [J]. Molecular cancer, 2015, 14(1):194.
[6] Zhang Xiao, Wei Xiaowei, Qi Jijin, et al. Simultaneous Detection of Bladder Cancer Exosomal MicroRNAs Based on Inorganic Nanoflare and DNAzyme Walker [J]. Analytical chemistry, 2022, 94(11):4787-4793.
[7] Chen Liangyuan, Cui Zhaolei, Liu Yaohua, et al. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis [J]. Clinical laboratory, 2015, 61(8):1101-1108.
[8] Miah S, Dudziec E, Drayton R M, et al. An evaluation of urinary microRNA reveals a high sensitivity for bladder cancer [J]. British journal of cancer, 2012, 107(1):123-128.
[9] Baumgart Sophie, Meschkat Pascal, Edelmann Philipp, et al. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer [J]. Journal of cancer research and clinical oncology, 2019, 145(11):2725-2736.
[10] Lin Hao, Shi Xiaojun, Li Haoran, et al. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer [J]. BMC Cancer, 2021, 21(1):1293-1293.
[11] Huang CS, Ho JY, Chiang JH, et al. Exosome-transmitted LINC00960 and LINC02470 promote the epithelial-mesenchymal transition and aggressiveness of bladder cancer cells [J]. Cells, 2020, 9(6):1419.
[12] Lin Fan, Yin Hu-Bin, Li Xin-Yuan, et al. Bladder cancer cell‑secreted exosomal miR‑21 activates the PI3K/AKT pathway in macrophages to promote cancer progression [J]. International journal of oncology, 2020, 56(1):151-164.
[13] Jia Yuefeng, Ding Xuemei, Zhou Lihua, et al. Mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1 [J]. Oncogene, 2020, 40(2):246-261.
[14] Cai Xiaoxiao, Qu Lili, Yang Jian, et al. Exosome-transmitted microRNA-133b inhibited bladder cancer proliferation by upregulating dual-specificity protein phosphatase 1 [J]. Cancer medicine, 2020, 9(16):6009-6019.
[15] Shan Guang, Zhou Xike, Gu Juan, et al. Downregulated exosomal microRNA-148b-3p in cancer associated fibroblasts enhance chemosensitivity of bladder cancer cells by downregulating the Wnt/β-catenin pathway and upregulating PTEN [J]. Cellular Oncology, 2021, 44(1):1-15.
[16] Wu, Alexander T. H. Srivastava, PrateetiYadav, Vijesh KumarTzeng, et al. Ovatodiolide, isolated from Anisomeles indica, suppresses bladder carcinogenesis through suppression of mTOR/beta-catenin/CDK6 and exosomal miR-21 derived from M2 tumor-associated macrophages [J].Toxicology and Applied Pharmacology, 2020, 401(1):115109.
[17] Yoshida Kazuhiko, Tsuda Masumi, Matsumoto Ryuji, et al. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer [J]. Cancer science, 2019, 110(7):2119-2132.
[18] Yan Lei, et al. Cancer-associated fibroblasts-derived exosomes-mediated transfer of LINC00355 regulates bladder cancer cell proliferation and invasion [J]. Cell biochemistry and function, 2020, 38(3):257-265.
[19] Cai Hongzhou, Yang Xuejian, Gao Yang, et al. Exosomal MicroRNA-9-3p Secreted from BMSCs Downregulates ESM1 to Suppress the Development of Bladder Cancer [J]. Molecular Therapy - Nucleic Acids, 2019, 18:787-800.
[20] Yin Xinbao, et al. Exosomal miR‐663b targets Ets2‐repressor factor to promote proliferation and the epithelial–mesenchymal transition of bladder cancer cells [J]. Cell Biology International, 2020, 44(4):958-965.
[21] Yang Chen, Wu Siqi, Mou Zezhong, et al. Exosome derived circTRPS1 promotes malignant phenotype and CD8+ T cell exhaustion in bladder cancer microenvironment through modulating reactive oxygen species equilibrium via GLS1 mediated glutamine metabolism alteration [J]. Molecular therapy : the journal of the American Society of Gene Therapy, 2022, 30(3):1054-1070.
[22] Yan Liang, et al. MiR-4644 is upregulated in plasma exosomes of bladder cancer patients and promotes bladder cancer progression by targeting UBIAD1 [J]. American journal of translational research, 2020, 12(10):6277-6289.
[23] Strømme Olaf, et al. Differentially Expressed Extracellular Vesicle-Contained microRNAs before and after Transurethral Resection of Bladder Tumors [J]. Current Issues in Molecular Biology, 2021, 43(1):286-300.
[24] Lin Jen-Tai, Tsai Kuo-Wang. Circulating miRNAs Act as Diagnostic Biomarkers for Bladder Cancer in Urine[J]. International Journal of Molecular Sciences, 2021, 22(8):4278-4278.
[25] Alexandru A. Sabo, Giovanni Birolo, Alessio Naccarati, et al. Small Non-Coding RNA Profiling in Plasma Extracellular Vesicles of Bladder Cancer Patients by Next-Generation Sequencing: Expression Levels of miR-126-3p and piR-5936 Increase with Higher Histologic Grades [J]. Cancers, 2020, 12(6):1-15.

Subscription

E-Mail Alert

Downloads:	391
Visits:	27978

Research Progress on the Expression of miRNA in the Diagnosis and Treatment of Bladder Urothelial Carcinoma

Author(s)

Affiliation(s)

Corresponding Author

ABSTRACT

KEYWORDS

CITE THIS PAPER

REFERENCES

RESOURCES

JOIN US

PUBLICATION SERVICES

CONTACT US